Researchers Find Arrays Miss Many CNVs; Recommend Combining Platforms, Algorithms to Improve Results | GenomeWeb

By Justin Petrone

An international team of scientists recently completed a "massive initiative" to evaluate the ability of available microarray platforms and accompanying algorithms to discover copy number variation in genes implicated in diseases.

Led by researchers at Uppsala University in Sweden and the Hospital for Sick Children in Toronto, the team tested 11 different microarray platforms and found that current methods of analysis only detect a portion of the CNVs in the genome in any given experiment.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: ancient Ethiopian genome indicates greater Eurasian backflow into Africa, sequencing to diagnose cutaneous T cell lymphoma, and more.

The US House of Representatives science committee has passed a bill to require NSF to ensure it only funds projects that are in the national interest.

DuPont teams with genome editing firm Caribou Biosciences for agricultural applications of the technology.

A blogger reviews her experience learning about her gut microbiome by shipping a sample to uBiome.